- New device can detect skin cancer in seconds. // South Asian Post;5/24/2012, p8
The article provides information on Verisante Aura, a device used for the diagnosis of melanoma, developed by the British Columbia Cancer Agency.
- Primary sinonasal malignant melanoma: A clinicopathologic and prognostic study. Kumar, Sudesh; Gupta, Ashok K.; Yadav, Budhi S.; Ghoshal, Sushmita // ENT: Ear, Nose & Throat Journal;Dec2009, Vol. 88 Issue 12, p1269
We conducted a retrospective study to evaluate the clinicopathologic features and prognostic factors associated with primary sinonasal malignant melanoma. We reviewed the records of 10 patients--7 men and 3 women, aged 35 to 70 years (mean: 51.4)--who had been treated at our referral center over...
- Leiomyoma of the Inferior Turbinates. Huang, Cheng-Tsung; Chien, Chih-Yen; Su, Chih-Ying; Chen, Wei-Jen // Journal of Otolaryngology;Jan/Feb2000, Vol. 29 Issue 1, p55
Reports on the case of a 20-year old man diagnosed with leiomyoma of the inferior turbinate of the nasal cavity. Medical history; Initial assessment; Pathologic findings; Occurrence of leiomyomas wherever the smooth muscle is present; Identification of three subtypes of leiomyoma;...
- British Columbia Cancer Agency Joins the Illumina Genome Network. // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1
The article presents information on an announcement made by Illumina Inc. on the joining of Genome Science Center of British Columbia Cancer Agency (BCCA) to the Illumina Genome Network (IGN). IGN is designed to link the researchers who need whole human genome sequencing with major institutions...
- The human genome leads back to BC. Kent, Heather // CMAJ: Canadian Medical Association Journal;1/23/2001, Vol. 164 Issue 2, p312
Profiles research scientist Marco Marra who works at the Genome Sequence Center at the British Columbia Cancer Agency. His works on projects involving the International Human Genome Project; His interest in endocrinology; How knowing a person's DNA sequence may influence the choice of drugs for...
- Extensive nasopharyngeal angiofibromas: the maxillary swing approach. Mathur, Neeraj; Vashishth, Ashish // European Archives of Oto-Rhino-Laryngology;Nov2014, Vol. 271 Issue 11, p3035
The objective of this study was to evaluate the efficacy and outcome using the maxillary swing approach for the management of extensive nasopharyngeal angiofibromas. A retrospective analysis in a tertiary care center revealed five cases with extensive nasal angiofibromas operated using the...
- Antrochoanal polyp displacing the uvula and the soft palate. Christmas, Dewey A.; Yanagisawa, Ken; Yanagisawa, Eiji // ENT: Ear, Nose & Throat Journal;May2003, Vol. 82 Issue 5, p347
Presents an examination of antrochoanal polyp displacing the uvula and the soft palate of a patient. Symptoms of the disorder; Diagnosis of antrochoanal polyp; Information on an endoscopic excision of the polyp performed on the patient.
- Extramedullary plasmacytoma of the nasal cavity: Treatment perspective in a developing nation. Grover, Nancy; Chary, Geetha; Makhija, Purnima; Rout, Pritilata // ENT: Ear, Nose & Throat Journal;Jul2006, Vol. 85 Issue 7, p434
Extramedullary plasmacytomas are uncommon tumors, with a worldwide annual incidence of 3 per 100,000 population. They account for 1% of all tumors of the head and neck and 4% of all nonepithelial tumors of the nasal tract. A variety of treatment options has been suggested. These treatments vary...
- Pleomorphic adenoma of nasal cavity: a case report. Aziz, Yasmeen; Hasan, S. A. // Indian Journal of Otolaryngology & Head & Neck Surgery;2010 Supplement 1, Vol. 62, p71
Presenting complaints of the patient is tumor mass in the nasal cavity. Histopathology revealed pleomorphic adenoma. Intranasal pleomorphic adenoma originates from nasal seromucous glands. Resection was done using lateral rhinotomy route.